1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Optic Neuropathy Ongoing Clinical Trials Overview, 2019
2.2 Premium Insights into Ongoing Clinical Trials
2.2.1 Ongoing Optic Neuropathy Clinical Trials by Region
2.2.2 Average Enrollment of Optic Neuropathy Clinical Trials
2.2.3 Companies participating in Ongoing Trials
2.2.4 Drugs under Study for Optic Neuropathy Treatment, 2019

3. Region wise Optic Neuropathy Clinical Trials
3.1 Asia Pacific Optic Neuropathy Clinical Trials by Country
3.2 Europe Optic Neuropathy Clinical Trials by Country
3.3 North America Optic Neuropathy Clinical Trials by Country
3.4 Middle East and Africa Optic Neuropathy Clinical Trials by Country
3.5 South and Central America Optic Neuropathy Clinical Trials by Country

4. Optic Neuropathy Clinical Trial Trends
4.1 Start Year wise Ongoing Optic Neuropathy Clinical Trials
4.2 Phase wise Ongoing Optic Neuropathy Clinical Trials
4.3 Trial Status wise Ongoing Optic Neuropathy Clinical Trials
4.4 Trial Type wise Ongoing Optic Neuropathy Clinical Trials

5. Optic Neuropathy Average Enrollment Trends
5.1 Average Enrollment in Optic Neuropathy Trials by Year
5.2 Average Enrollment in Optic Neuropathy Trials by Phase
5.3 Average Enrollment in Optic Neuropathy Trials by Status
5.4 Average Enrollment in Optic Neuropathy Trials by Type of Trial

6. Companies Participating in Ongoing Optic Neuropathy Clinical Trials
6.1 Ongoing Optic Neuropathy Trials by Sponsor Type
6.2 Optic Neuropathy Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Ongoing Optic Neuropathy Trials- Phase 1
7.2 Ongoing Optic Neuropathy Trials- Phase 2
7.3 Ongoing Optic Neuropathy Trials- Phase 3
7.4 Ongoing Optic Neuropathy Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Optic Neuropathy Ongoing Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Ongoing Optic Neuropathy Clinical Trials and Enrolment
Figure 5: Europe – Country wise Ongoing Optic Neuropathy Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Ongoing Optic Neuropathy Clinical Trials and Enrolment
Figure 7: North America – Country wise Ongoing Optic Neuropathy Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Ongoing Optic Neuropathy Clinical Trials and Enrolment
Figure 9: Optic Neuropathy Ongoing Clinical Trials by Phase
Figure 10: Optic Neuropathy Ongoing Clinical Trials by Trial Status
Figure 11: Optic Neuropathy Ongoing Clinical Trials by Type
Figure 12: Optic Neuropathy Ongoing Clinical Trials by Sponsor Type
Figure 13: Optic Neuropathy Ongoing Clinical Trials by Leading Sponsors
Figure 14: Optic Neuropathy Average Enrollment by Phase
Figure 15: Optic Neuropathy Average Enrollment by Trial Status
Figure 16: Optic Neuropathy Average Enrollment by Type
Figure 17: Optic Neuropathy- Average Enrolment by Type of Sponsors
Figure 18: Optic Neuropathy- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Optic Neuropathy Ongoing Clinical Trials Snapshot- 2019
Table 2: Ongoing Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Ongoing Optic Neuropathy Clinical Trials and Enrolment
Table 5: Europe – Country wise Ongoing Optic Neuropathy Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Ongoing Optic Neuropathy Clinical Trials and Enrolment
Table 7: North America – Country wise Ongoing Optic Neuropathy Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Ongoing Optic Neuropathy Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Optic Neuropathy Average Enrollment by Phase
Table 15: Optic Neuropathy Average Enrollment by Trial Status
Table 16: Optic Neuropathy Average Enrollment by Type
Table 17: Optic Neuropathy- Average Enrolment by Type of Sponsors
Table 18: Optic Neuropathy- Enrolment by Leading Sponsors